Search the Newsreel

Valneva SE - Depositary receipt (VALN) price target decreased by 17.41% to 14.35

This article reports a significant decrease in the price target for Valneva SE (VALN) depositary receipts. The target has been cut by 17.41%, bringing it down to 14.35. No further details regarding the reasons for this adjustment are provided.

D.E. Shaw discloses net short position in Valneva

D.E. Shaw has disclosed a 0.69% net short position in Valneva. This news brief was generated by Public Technologies using AI and is based on content published by Valneva SE on July 17, 2026. The information is for informational purposes only and not financial …

The VLA2001 COVID-19 Vaccine - Valneva bets on travel-ready protection

Valneva SE's VLA2001 is an inactivated whole-virus COVID-19 vaccine targeting adults, especially frequent travelers, who prefer traditional vaccine technology. The vaccine is authorized in the UK and recommended in Europe for individuals aged 18 to 50, showcasing non-inferiority to other vaccines with a potentially …

Valneva SE: Objectif de Cours et Consensus des Analystes | VLA | FR0004056851

Valneva chute puis remonte après ses résultats T1

Action Valneva : le titre touche sa résistance après la publication du chiffre d'affaires 2025

Valneva SE gibt Ergebnisprognose für das Jahr 2026 bekannt

Valneva Aktie Prognose: Kursziele von Drittanbietern

Valneva : De nouveaux résultats cliniques positifs sur son vaccin contre la maladie de Lyme portent Valneva en Bourse

Valneva reporte sa dette à 2030 et ajuste ses prévisions à la baisse

Valneva SE: Finanzdaten Prognosen Schätzungen und Erwartungen | A0MVJZ | FR0004056851

Valneva SE: Prévisions et Estimations des Analystes | VLA

Valneva SE: Analyse Fondamentale et Notations Financières | VLA | FR0004056851

Valneva SE: Konsensus der Analysten und Kursziel | A0MVJZ | FR0004056851